Global Medical Aesthetics Market - Segment Analysis, Opportunity Assessment, Competitive Intelligence, Industry Outlook 2016-2026

Date : Apr 2020

|

Report ID : 231

|

Category : Healthcare

|
Report Format:  PDF EXCEL PPT WORD

The global medical aesthetics market was valued at USD 10.1 billion in 2018 and is expected to reach USD 20.4 billion in 2026, growing at a CAGR of 9.0% during the forecast period.

Medical aesthetics is a procedure-oriented treatment is used to enhance an individual’s appearance. This includes improvement in person’s aesthetic appearance, such as excessive fat, wrinkles, moles, skin laxity, unwanted hair, skin discoloration, and liver spots, among others.

The major factors that are encouraging the market growth include rising per capita income, a significant rise in the personal care industry, and growing R&D investment for medical aesthetics devices. The rapid growing aging population and considerable focus on personal grooming are primarily driving the demand for skincare products. For instance, as per the United Nations (UN), by 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%). Due to this rise in the aging population, the manufacturers of medical aesthetics products have introduced anti-aging solutions that help to reduce and prevent signs of skin aging. Moreover, increasing trend of minimally invasive and non-invasive surgical procedures is further driving the growth of the market.

Medical Aesthetics Market Segmentation

         By Product Type 1. Facial Aesthetics Products
2. Body Contouring Devices
3. Cosmetic Implants
4. Hair Removal Devices
5. Others
 
        By End-Users 1. Hospitals and Clinics
2. Beauty Centres
3. Homecare
 
          By Region 1. North America (US and Canada)
2. Europe (UK, Germany, France and Rest of Europe)
3. Asia Pacific (China, Japan, India and Rest of Asia Pacific)
4. Latin America (Brazil, Mexico and Rest of Latin America)
5. Middle East & Africa (GCC and Rest of Middle East & Africa)
 


The facial aesthetics products segment contributes a major share in the global market

Based on product type, the global medical aesthetics market has been segmented into facial aesthetics products, body contouring devices, cosmetic implants, hair removal devices, and others. The facial aesthetics products segment is accounted for the largest share in the market and held for around 35% of the total market in 2018. Among these products, the facial aesthetics products segment registers a remarkable share in the market due to its increasing demand among the geriatric population.

Based on end-user, the homecare segment is expected to grow at the fastest rate of CAGR 11.5% during the forecast period

Based on end-users, the market has been segmented into hospitals and clinics, beauty centres, and homecare. The homecare segment accounted to project considerable growth in the market in 2018 and expected to grow at the highest CAGR of around 11.5% during the forecast period. The demand for homecare-based medical aesthetics products is due to the rising trend of compact and affordable medical services in developed economies, such as the US. The key market players are developing homecare medical aesthetics products for the continuously growing economies.

Global Medical Aesthetics Market Size, 2016-2026, (US$ Bn)

Medical Aesthetics Market


North America to dominate the medical aesthetics market throughout the forecast period

North America accounted for nearly 35% share of the global medical aesthetics market in 2018 and is expected to dominate the market throughout the forecast period, followed by Europe. The factors that are contributing to the market growth in these regions include a significant rise in aging population, R&D investment in personal care products and rising demand for naturally sourced ingredients in cosmetic products. Moreover, the presence of well-developed healthcare infrastructure, growing prevalence of skin disorders, and increasing adoption of technologically advanced aesthetic devices. Asia-Pacific accounted for the highest CAGR in the global medical aesthetics market during the forecast period.

Company Profiles and Competitive Intelligence:

The major players operating in the global medical aesthetics market are Allergan PLC (Ireland), Cutera (US), Fotona d.o.o. (Slovenia), Galderma Laboratories, L.P. (US), Anika Therapeutics, Inc. (US), Merz Pharma GmbH & Co.KGaA (Germany), Candela Corporation (US), Sientra, Inc. (US), Sinclair Pharma Ltd. (UK), and Alma Laser GmbH (Germany) among others.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

TABLE OF CONTENT

Chapter 1 Executive Summary

1.1. Market Summary

1.1.1. Global Medical Aesthetics Market, 2016-2026, (USD Million)

1.2. Market Snapshot: Global Medical Aesthetics Market

1.3. Market Dynamics

1.4. Global Medical Aesthetics Market, by Segment, 2018

1.4.1. Global Medical Aesthetics Market, by Product Type, 2018, (USD Million)

1.4.2. Global Medical Aesthetics Market, by End-User, 2018, (USD Million)

1.4.3. Global Medical Aesthetics Market, by Region, 2018 (USD Million)

1.5. Premium Insights

1.5.1. Medical Aesthetics Market In Developed Vs. Developing Economies, 2018 vs 2026

1.5.2. Global Medical Aesthetics Market: Regional Life Cycle Analysis

Chapter 2 Market Dynamics

2.1. Market Overview

2.2. Market Drivers

2.2.1. Increasing trend of minimally invasive aesthetic procedures

2.2.2. Growing geriatric population

2.3. Market Restraints

2.3.1. Availability of alternative beauty and cosmetic products

2.4. Market Opportunities

2.4.1. Innovation in homecare aesthetic devices

2.4.2. Increasing disposable income

2.5. Industry Value Chain Analysis

2.6. Pricing Analysis

2.7. Porter’s Five Forces Analysis

Chapter 3 Global Medical Aesthetics Market, by Product Type

3.1. Market Overview, by Product Type

3.1.1. Global Medical Aesthetics Market, by Product Type, 2016-2026 (USD Million)

3.1.2. Incremental Opportunity, by Product Type, 2018

3.2. Facial Aesthetic Products

3.2.1. Global Medical Aesthetics Market, by Facial Aesthetic Products, 2016-2026, (USD Million)

3.3. Body Contouring Devices

3.3.1. Global Medical Aesthetics Market, by Body Contouring Devices, 2016-2026, (USD Million)

3.4. Cosmetic Implants

3.4.1. Global Medical Aesthetics Market, by Cosmetic Implants, 2016-2026, (USD Million)

3.5. Hair Removal Devices

3.5.1. Global Medical Aesthetics Market, by Hair Removal Devices, 2016-2026, (USD Million)

3.6. Others

3.6.1. Global Medical Aesthetics Market, by Others, 2016-2026, (USD Million)

Chapter 4 Global Medical Aesthetics Market, by End-User

4.1. Market Overview, by End-User

4.1.1. Global Medical Aesthetics Market, by End-User, 2016-2026 (USD Million)

4.1.2. Incremental Opportunity, by End-User, 2018

4.2. Hospitals and Clinics

4.2.1. Global Medical Aesthetics Market, by Hospitals and Clinics, 2016-2026, (USD Million)

4.3. Beauty Centers

4.3.1. Global Medical Aesthetics Market, by Beauty Centers, 2016-2026, (USD Million)

4.4. Homecare

4.4.1. Global Medical Aesthetics Market, by Homecare, 2016-2026, (USD Million)

Chapter 5 Global Medical Aesthetics Market, by Region

5.1. Market Overview, by Region

5.1.1. Global Medical Aesthetics Market, by Region, 2016-2026, (USD Million)

5.2. Attractive Investment Opportunity, by Region, 2018

5.3. North America Medical Aesthetics Market

5.3.1. North America Medical Aesthetics Market, by Product Type, 2016-2026 (USD Million)

5.3.2. North America Medical Aesthetics Market, by End-User, 2016-2026 (USD Million)

5.3.3. United States Medical Aesthetics Market, 2016-2026 (USD Million)

5.3.4. Canada Medical Aesthetics Market, 2016-2026 (USD Million)

5.4. Europe Medical Aesthetics Market

5.4.1. Europe Medical Aesthetics Market, by Product Type, 2016-2026 (USD Million)

5.4.2. Europe Medical Aesthetics Market, by End-User, 2016-2026 (USD Million)

5.4.3. United Kingdom Medical Aesthetics Market, 2016-2026 (USD Million)

5.4.4. Germany Medical Aesthetics Market, 2016-2026 (USD Million)

5.4.5. France Medical Aesthetics Market, 2016-2026 (USD Million)

5.4.6. Rest of Europe Medical Aesthetics Market, 2016-2026 (USD Million)

5.5. Asia Pacific Medical Aesthetics Market

5.5.1. Asia Pacific Medical Aesthetics Market, by Product Type, 2016-2026 (USD Million)

5.5.2. Asia Pacific Medical Aesthetics Market, by End-User, 2016-2026 (USD Million)

5.5.3. China Medical Aesthetics Market, 2016-2026 (USD Million)

5.5.4. Japan Medical Aesthetics Market, 2016-2026 (USD Million)

5.5.5. India Medical Aesthetics Market, 2016-2026 (USD Million)

5.5.6. Rest of Asia Pacific Medical Aesthetics Market, 2016-2026 (USD Million)

5.6. Latin America Medical Aesthetics Market

5.6.1. Latin America Medical Aesthetics Market, by Product Type, 2016-2026 (USD Million)

5.6.2. Latin America Medical Aesthetics Market, by End-User, 2016-2026 (USD Million)

5.6.3. Brazil Medical Aesthetics Market, 2016-2026 (USD Million)

5.6.4. Mexico Medical Aesthetics Market, 2016-2026 (USD Million)

5.6.5. Rest of Latin America Medical Aesthetics Market, 2016-2026 (USD Million)

5.7. Middle East & Africa Medical Aesthetics Market

5.7.1. Middle East & Africa Medical Aesthetics Market, by Product Type, 2016-2026 (USD Million)

5.7.2. Middle East & Africa Medical Aesthetics Market, by End-User, 2016-2026 (USD Million)

5.7.3. GCC Medical Aesthetics Market, 2016-2026 (USD Million)

5.7.4. Rest of Middle East & Africa Medical Aesthetics Market, 2016-2026 (USD Million)

Chapter 6 Competitive Intelligence

6.1. Top 5 Players Comparison

6.2. Market Positioning of Key Players, 2018

6.3. Market Players Mapping

6.3.1. By Product Type

6.3.2. By End-User

6.3.3. By Region

6.4. Strategies Adopted by Key Market Players

6.5. Recent Developments in the Market

6.5.1. Mergers & Acquisitions, Partnership, New Type Developments

Chapter 7 Company Profiles

7.1. Allergan PLC

7.1.1. Allergan PLC Overview

7.1.2. Allergan PLC Types Portfolio

7.1.3. Allergan PLC Financial Overview

7.1.4. Allergan PLC News/Recent Developments

7.2. Cutera

7.2.1. Cutera Overview

7.2.2. Cutera Types Portfolio

7.2.3. Cutera Financial Overview

7.2.4. Cutera News/Recent Developments

7.3. Fotona d.o.o.

7.3.1. Fotona d.o.o. Overview

7.3.2. Fotona d.o.o. Types Portfolio

7.3.3. Fotona d.o.o. Financial Overview

7.3.4. Fotona d.o.o. News/Recent Developments

7.4. Galderma Laboratories, L.P.

7.4.1. Galderma Laboratories, L.P. Overview

7.4.2. Galderma Laboratories, L.P. Types Portfolio

7.4.3. Galderma Laboratories, L.P. Financial Overview

7.4.4. Galderma Laboratories, L.P. News/Recent Developments

7.5. Anika Therapeutics, Inc.

7.5.1. Anika Therapeutics, Inc. Overview

7.5.2. Anika Therapeutics, Inc. Types Portfolio

7.5.3. Anika Therapeutics, Inc. Financial Overview

7.5.4. Anika Therapeutics, Inc. News/Recent Developments

7.6. Merz Pharma GmbH & Co.KGaA

7.6.1. Merz Pharma GmbH & Co.KGaA Overview

7.6.2. Merz Pharma GmbH & Co.KGaA Types Portfolio

7.6.3. Merz Pharma GmbH & Co.KGaA Financial Overview

7.6.4. Merz Pharma GmbH & Co.KGaA News/Recent Developments

7.7. Candela Corporation

7.7.1. Candela Corporation Overview

7.7.2. Candela Corporation Types Portfolio

7.7.3. Candela Corporation Financial Overview

7.7.4. Candela Corporation News/Recent Developments

7.8. Sientra, Inc.

7.8.1. Sientra, Inc. Overview

7.8.2. Sientra, Inc. Types Portfolio

7.8.3. Sientra, Inc. Financial Overview

7.8.4. Sientra, Inc. News/Recent Developments

7.9. Sinclair Pharma Ltd.

7.9.1. Sinclair Pharma Ltd. Overview

7.9.2. Sinclair Pharma Ltd. Types Portfolio

7.9.3. Sinclair Pharma Ltd. Financial Overview

7.9.4. Sinclair Pharma Ltd. News/Recent Developments

7.10. Alma Laser GmbH

7.10.1. Alma Laser GmbH Overview

7.10.2. Alma Laser GmbH Types Portfolio

7.10.3. Alma Laser GmbH Financial Overview

7.10.4. Alma Laser GmbH News/Recent Developments

Chapter 8 Preface

8.1. Data Triangulation

8.2. Research Methodology

8.2.1. Phase I – Secondary Research

8.2.2. Phase II – Primary Research

8.2.3. Phase III – Expert Panel Review

8.2.4. Approach Adopted

8.2.4.1. Top-Down Approach

8.2.4.2. Bottom-Up Approach

8.2.5. Supply- Demand side

8.2.6. Breakup of the Primary Profiles

 


Choose License
Buy Now
Why Choose AllTheResearch?
  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on “Quadrant Positioning” of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports. Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.


Quick Inquiry
Follow Us
Choose License
Buy Now